Studying Impact of Religiosity and Spirituality on Depression and Anxiety

Religiosity and spirituality are fundamental aspects of the human experience, shaping beliefs, values, and how individuals navigate life's challenges. Religiosity refers to the degree to which individuals identify with, and participate in the practices and beliefs of, a particular religion. It encompasses behaviors like prayer, attending religious services, and following religious teachings. Spirituality, on the other hand, is a broader concept that reflects a sense of connection to something larger than oneself, a search for meaning and purpose in life. This connection can be expressed through religious beliefs, but it can also be independent of religion, encompassing a connection to nature, humanity, or a sense of purpose. Research has increasingly explored the complex interplay between these constructs and mental health. The relationship between religiosity/spirituality and mental health is multifaceted. Religious involvement can provide individuals with social support, a sense of belonging, and a framework for coping with stress. Spiritual beliefs can offer comfort, hope, and a sense of purpose, potentially promoting resilience in the face of challenges. However, the relationship is not always straightforward. Certain religious beliefs or practices could contribute to feelings of guilt, shame, or isolation, potentially impacting mental health. Additionally, negative religious coping styles, such as feeling angry or abandoned by God, might exacerbate mental health problems. Given the centrality of religion in the Arab world, including Egypt, a deeper look into the associations between religiosity/spirituality and psychiatric disorders such as depression and anxiety is warranted.

• Inclusion Criteria:

• Age above 18 years old.
• Diagnosed with Depression and/or Anxiety disorders according to the DSM-5 criteria.
• Exclusion Criteria:

• Severe psychiatric disorders including schizophrenia, personality disorders and drug-use disorders.
• Patients with cognitive impairment.
• Severe comorbid medical condition or disabilities including metabolic diseases and neurological disabilities.